English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [912]
News [3695]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
Secrets of lung cancer spread found in patients' blood and biopsies
Secrets of lung cancer spread found in patients' blood and biopsies
New evolution-busting drug overcomes resistance in aggressive breast cancers
New evolution-busting drug overcomes resistance in aggressive breast cancers
Nanotech turns pro-tumour immune cells into cancer-killing triple agents
Nanotech turns pro-tumour immune cells into cancer-killing triple agents
ESMO 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy
ESMO 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy
ESMO 2019: New combination therapy offers bowel cancer patients extra treatment option
ESMO 2019: New combination therapy offers bowel cancer patients extra treatment option
ESMO 2019: PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients
ESMO 2019: PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients
ESMO 2019: Liquid biopsy has prognostic role in colorectal cancer and potential for guiding therapy
ESMO 2019: Liquid biopsy has prognostic role in colorectal cancer and potential for guiding therapy
ESMO 2019: One in two patients with metastatic melanoma alive after five years with combination immunotherapy
ESMO 2019: One in two patients with metastatic melanoma alive after five years with combination immunotherapy
ESMO 2019: DNA profiling may hold key to better treatment options in carcinoma of unknown primary
ESMO 2019: DNA profiling may hold key to better treatment options in carcinoma of unknown primary
ESMO 2019: Clinical benefit with first-line immunotherapy in advanced hepatocellular carcinoma
ESMO 2019: Clinical benefit with first-line immunotherapy in advanced hepatocellular carcinoma
<1...9899100101102...370>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top